Human tryptophanyl-tRNA synthetase is switched to a tRNA-dependent mode for tryptophan activation by mutations at V85 and I311 by Guo, Li-Tao et al.
5934–5943 Nucleic Acids Research, 2007, Vol. 35, No. 17 Published online 28 July 2007
doi:10.1093/nar/gkm633
Human tryptophanyl-tRNA synthetase is switched
to a tRNA-dependent mode for tryptophan










1State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031 and
2Department of
Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kwoloon, Hong Kong, China
Received April 28, 2007; Revised and Accepted August 2, 2007
ABSTRACT
For most aminoacyl-tRNA synthetases (aaRS),
their cognate tRNA is not obligatory to catalyze
amino acid activation, with the exception of four
class I (aaRS): arginyl-tRNA synthetase, glutamyl-
tRNA synthetase, glutaminyl-tRNA synthetase and
class I lysyl-tRNA synthetase. Furthermore, for
arginyl-, glutamyl- and glutaminyl-tRNA synthetase,
the integrated 3’ end of the tRNA is necessary
to activate the ATP-PPi exchange reaction.
Tryptophanyl-tRNA synthetase is a class I aaRS
that catalyzes tryptophan activation in the absence
of its cognate tRNA. Here we describe mutations
located at the appended b1–b2 hairpin and the AIDQ
sequence of human tryptophanyl-tRNA synthetase
that switch this enzyme to a tRNA-dependent mode
in the tryptophan activation step. For some mutant
enzymes, ATP-PPi exchange activity was com-
pletely lacking in the absence of tRNA
Trp, which
could be partially rescued by adding tRNA
Trp,
even if it had been oxidized by sodium periodate.
Therefore, these mutant enzymes have strong
similarity to arginyl-tRNA synthetase, glutaminyl-
tRNA synthetase and glutamyl-tRNA synthetase in
their mode of amino acid activation. The results
suggest that an aaRS that does not normally require
tRNA for amino acid activation can be switched to a
tRNA-dependent mode.
INTRODUCTION
Aminoacyl-tRNA synthetases (aaRS) catalyze the ester-
iﬁcation of an amino acid to the 30-end of its cognate
tRNA in a two-step reaction. In the ﬁrst step, the amino
acid is activated in the form of an enzyme-bound
aminoacyl–adenylate intermediate, while the second step
involves the transfer of the amino acid to the 30-end of
its cognate tRNA to produce an aminoacyl-tRNA (1).
Based on two distinct ATP-binding cores, the 20 aaRSs
are equally divided into two classes (2,3). In most cases,
formation of the aminoacyl-adenylate does not require
the presence of its cognate tRNA and can be performed by
the isolated catalytic domain of some synthetases (4,5).
However,forthreeclassIsynthetases,arginyl-,glutaminyl-
and glutamyl-tRNA synthetase (ArgRS, GlnRS and
GluRS, respectively), as well as the exceptional class I
lysyl-tRNA synthetase (LysRS), tRNAs are absolutely
required to accomplish the ﬁrst step of the reaction.
The requirement of tRNA in aminoacyl-adenylate
formation has been conﬁrmed for ArgRS from diﬀerent
sources (6–11) and is likely a common feature of this
enzyme. An intact 30-terminal adenosine of its cognate
tRNA is also required, because arginine activation cannot
be induced by periodate-treated tRNA (7,9,10,12,13).
Proper tRNA structure is also necessary for arginine
activation (13). For GluRS and GlnRS, amino acids also
cannot be activated without their cognate tRNA (14–17).
The activator function also requires the integrity of the 30
terminus of the tRNA, and chemical modiﬁcation of this
terminus abolishes this activity (14,16,18). Exceptionally,
several bacteria and archaea have the class I-type LysRS
instead of the class II-type LysRS (19,20). Class I LysRS is
structurally related to GluRS (21), and does not catalyze
lysyl-adenylate formation in the absence of tRNA (22).
However, the biological signiﬁcance of requiring tRNA
to activate amino acids remains puzzling. The fact that
ArgRS requires its cognate tRNA to activate arginine has
led to the suggestion that the arginyl–adenylate inter-
mediate does not exist in the arginylation reaction (23),
although Kern and Lapointe (24,25) later demonstrated
that GluRS charges tRNA with glutamate in two steps
and that the glutamyl–adenylate intermediate exists,
despite the fact that tRNA is needed for the ﬁrst step.
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a class I aaRS, and together with all other synthetases
except for ArgRS, GluRS, GlnRS and class I LysRS, can
activate an amino acid substrate smoothly in the absence
of cognate tRNA (1). We recently showed that the ATP-
PPi exchange reaction of a mutated Bacillus subtilis TrpRS
can be modulated by its inactivated tRNA
Trp (26).
Eukaryotic TrpRS diﬀers from prokaryotic TrpRS in
containing an appended N-terminus. For human TrpRS,
the N-terminal domain is composed of an appended
peptide and an eukaryote-speciﬁc patch (E82–K154)
containing a b1–b2 hairpin structure adjacent to the
ATP-binding pocket and the KMSAS loop (27). Deletion
of this hairpin severely reduces aminoacylation activity,
suggesting that human TrpRS has a more complicated
aminoacylation mechanism than B. subtilis TrpRS. At the
b1–b2 hairpin of human TrpRS (1R6T from the Protein
Data Bank), the backbone of V85 and V90 form a
hydrogen bond. The side chains of the two valines
protrude into the catalytic domain, which looks like
a buckhorn (Figure 1A).
In this study, we mutated V85 and V90 and unexpect-
edly found that the V85S mutant could no longer activate
tryptophan even though its tryptophanylation activity still
proceeded normally. Furthermore, we conﬁrmed that the
tryptophan activation of V85S can be partially rescued by
the addition of bovine tRNA
Trp. We constructed further
mutants at V85 to further investigate and found that the
V85E mutation also caused a switch to a tRNA-dependent
mode of amino acid activation, just like ArgRS, GluRS,
GlnRS and class I LysRS. Structural analysis showed
that V85 can interact with I311 through a hydrophobic
interaction to aﬀect tryptophan activation, which was
conﬁrmed by I311 mutations. The results indicate that an
aaRS that does not normally require tRNA for amino





Trp was expressed in Escherichia coli JM109
and human TrpRS and its mutants were expressed in
E. coli BL21-CodonPlus (DE3)-RIL. BL21-CodonPlus
(DE3)-RIL was purchased from Stratagene (La Jolla, CA,
USA). The bovine tRNA
Trp gene was cloned into the
pGEM-9Zf (–) plasmid obtained from Promega
(Madison, WI, USA) and was a kind gift from Dr Xue
Hong at the Hong Kong University of Science and
Technology. The plasmid pTrc-hTrpRS containing the
human trpS gene was also a gift from Dr Xue Hong.
Figure 1. Primary and tertiary structure of human TrpRS. (A) Crystal structure of full-length human TrpRS (40). The tryptophanyl–AMP
intermediate is indicated by an arrowhead. The V85 and I311 interface between the b1–b2 hairpin and main body is enlarged in the boxed inset.
(B) Primary sequence alignment of the region of human TrpRS containing the b1–b2 hairpin. The conserved V85 and V90 in TrpRSs are indicated
by arrowheads.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5935The human trpS gene expression vector pET24a (+) was
purchased from Novagen.
Sequencehomologyanalysis andstructure comparison
TrpRS protein sequences from archaebacteria and eukary-
otes were downloaded from the aaRS database (www.
pozman.edu.pl/aars) (28). Abbreviations of the species are
as follows: E-Hs, Homo sapiens; E-Bt, Bos taurus; E-Ms,
Mus musculus; E-Dm, Drosophila melanogaster; E-Ce,
Caenorhabditis elegans; E-Sp, Schizosaccharomyces
pombe; E-Ec, Encephalitozoon cuniculi; A-St, Sulfolobus
tokodaii; A-Su, Sulfolobus solfataricus; A-Pa, Pyrococcus
abyssi; A-Pf, Pyrococcus furiosus; A-Pe, Pyrobaculum
aerophilum. The ﬁrst letter E in the abbreviation means
eukaryote, and A means archaea. Multiple sequence
alignments were carried out with Clustal X 1.83 software
(ftp-igbmc.u-strasbg.fr/pub/ClustalX/). The pdb ﬁles of
human TrpRSs (1O5T, 1R6T, 1ULH and 2DR2) were
downloaded from the Protein Data Bank (http://www.
rcsb.org/pdb/). Structure comparisons and ﬁgure produc-
tion were carried out with Swiss-PdbViewer 3.7 software,
which was downloaded from http://www.expasy.ch/
spdbv/text/download.htm. The operation pathway of
Swiss-PdbViewer 3.7 software for structure comparison
was Fit\Magic Fit\CA (carbon alpha) only\.
Expression and purification of human TrpRSand bovine
tRNA
Trp
Expression and puriﬁcation of human TrpRS were
carried out as described previously (29). Concentrations
of puriﬁed proteins were determined with the Bradford
reagent (30). Mutagenesis was carried out by PCR
as described previously (31). Mutant human TrpRS
genes were veriﬁed by DNA sequencing. Abbreviations
of the mutations were as follows: V85A, valine 85 to
alanine; V85E, valine 85 to glutamate; V85K, valine 85
to lysine; V85L, valine 85 to leucine; V85S, valine 85 to
serine; V90A, valine 90 to alanine; V90S, valine 90
to serine; V85A/V90A, V85A/V90A double mutations;
I311V, isoleucine 311 to valine; I311E, isoleucine 311 to
glutamate. The bovine tRNA
Trp used for the enzyme
activity assay was expressed and puriﬁed as described
previously (32).
Periodate oxidation of tRNA
The oxidation of tRNA by sodium periodate was carried
out as previously described (33,34) with some modiﬁca-
tions. Bovine tRNA
Trp was treated with 10mM sodium
periodate in 1ml of 150mM sodium acetate (pH 5.3),
incubated at 48C in the dark for 1h. Glucose was then
added to a ﬁnal concentration of 10mM to remove excess
sodium periodate. The tRNA was incubated at 378C for
30min and then precipitated with ethanol.
Enzymatic assays
The ATP-PPi exchange reaction was assayed at 308Ci n
a reaction mixture containing 100mM Tris–HCl pH 7.8,
10mM potassium ﬂuoride, 10mM magnesium chloride,
4mM ATP, 0.02mCi [g-
32P]ATP, 4mM sodium pyrophos-
phate and 2mM tryptophan in total volume of 20ml.
Reactions were initiated by the addition of 0.2mM
enzyme. At each time point, samples were quenched on
ice. One microliter of the reaction mixture was spotted
onto PEI cellulose TLC plates (purchased from Merck,
Germany) and developed in 1M KH2PO4 and 1M urea to
separate the ATP and PPi. The radioactivity was revealed
and quantiﬁed using a PhosphorImager
TM (Molecular
Dynamics, Little Chalfont, Bucks, UK).
For mutants V85S, V85E, V85K, V85A/V90A and
I311E, the tRNA-dependent ATP-PPi exchange reaction
was assayed. Wild-type bovine tRNA
Trp and oxidized
bovine tRNA
Trp were added to the PPi exchange reaction
mixture to a ﬁnal concentration of 60mM. The other
components for the reaction were identical to that
described above.
The aminoacylation assay was also carried out at 308C
in a mixture containing 4mM ATP, 0.8mM DTT, 1mCi
L-[5-
3H]tryptophan, 12mM L-tryptophan, 8mM MgCl2,
80mM Tris–HCl, pH 7.5 and 12mM puriﬁed bovine
tRNA
Trp in a total volume of 50ml. Reactions were
initiated by the addition of 50nM enzyme. At each time
point, samples were quenched on ice and 20ml aliquots
were spotted onto ﬁlter paper disks, which were washed
three times with ice-cold 5% trichloroacetic acid contain-
ing 0.05% tryptophan and with cold anhydrous ethanol,
dried and transferred into vials for determination of
radioactivity. For all kinetic assays, the concentration
of tRNA
Trp varied from 0.2 to 12.8mM. Each reaction
was repeated at least four times under the same condi-
tions. The kcat/Km for aminoacylation was calculated
from Eadie–Hofstee plots. All data were ﬁtted to the
Michaelis–Menten equation.
RESULTS
The V85S mutationenables human TrpRS toswitch to
tRNA-dependent tryptophan activation
Based on a structural analysis of human TrpRS, we found
that there were two adjacent valines in the middle of the
b1 and b2 sheet, V85 and V90, whose side chains both
approach the substrate-binding pocket (Figure 1A). The
b1–b2 hairpin is essential to the aminoacylation activity
of human TrpRS (27), and therefore these two valine
residues may be important for enzyme activity. Based on
sequence alignment, we found that V85 and V90 are
conserved in eukaryotes and archaebacteria (Figure 1B).
Therefore, we constructed mutations at these two posi-
tions, V85 and V90, to generate the V85A, V85S, V90A
and V90S variants.
In the ATP-PPi exchange reaction, the V85A, V90A and
V90S mutants showed decreased, but visible tryptophan
activation activity, with V85A having the lowest enzyme
activity (Figure 2A). Furthermore, when V85 was mutated
to serine, no ATP-PPi exchange activity was detected,
even at a very high enzyme concentration (5.1mM)
(Figure 2A). Unexpectedly, the aminoacylation activity
of the V85S mutant remained comparable to the other
three mutant enzymes (Figure 2B) and could not catalyze
the tryptophanylation reaction in the absence of
5936 Nucleic Acids Research, 2007, Vol. 35, No. 17ATP (Figure 2B). This suggested that the aminoacylation
reaction of the V85S mutant proceeds normally and that
the mutation does not change the recognition of ATP.
These results implied that the V85S mutant might be
able to activate tryptophan only in the presence of tRNA.
To investigate whether the V85S mutant assumes a
tRNA-dependent ATP-PPi exchange activity, wild-type
or sodium periodate-treated bovine tRNA
Trp was added
to the ATP-PPi exchange reaction mixture. Unexpectedly,
both the wild type and the sodium periodate-treated
bovine tRNA
Trp were able to partially rescue the ATP-PPi
exchange activity of the V85S mutant (Figure 2C).
Sodium pyrophosphate can greatly inhibit the tryptopha-
nylation reaction. After adding the wild-type tRNAs
to the ATP-PPi exchange reaction, the tryptophanyl-
tRNA
Trp could hardly be detected (data not shown).
Thus, the tRNA-independent ATP-PPi exchange reaction
for human TrpRS is switched to a tRNA-dependent
mode by the single V85S mutation. However, in contrast
to ArgRS, GlnRS and GluRS (7,9,10,12–14,16,18), the
integrity of the 30 terminus of the tRNA was not necessary
for the ATP-PPi exchange activity of the V85S mutant
(Figure 2C). Therefore, it is reasonable to conclude that
human TrpRS is switched to a ‘nonproductive’ form by
V85S mutation but can be induced to a ‘productive’ form
by tRNA binding. Comparing Figure 2A B, we conclude
that V85 mutations have a greater impact on tryptophan
activation than the tryptophanylation reaction.
Additional mutants ofvaline 85
To further investigate the role of the V85 residue in the
ATP-PPi exchange reaction, we constructed three more
mutations at this position including V85L, V85E and
V85K. Relative to the V85E and V85K mutations, the
V85L mutant did not show a large decrease in tryptophan
activation (Figure 3A). However, the V85E and V85K
mutants lacked the ATP-PPi exchange activity of human
TrpRS under normal conditions (Figure 3A), just like the
V85S mutant (Figure 2A). In the tryptophanylation
reaction, the V85L mutant was able to acylate bovine
tRNA
Trp with very high eﬃciency (Figure 3B). Similar to
the V85S mutant, the V85E mutant has low but noticeable
activity (Figure 3B). In contrast, the V85K mutant had
barely detectable aminoacylation activity (Figure 3B).
In the presence of oxidized bovine tRNA
Trp, the V85E
TrpRS was unable to catalyze the ATP-PPi exchange
reaction, but the wild-type bovine tRNA
Trp could still
serve as an activator (Figure 3C), which suggests that the
hydroxyl groups of the 30 adenosine of tRNA can also
activate human TrpRS. For the V85K mutant, wild-
type tRNA could slightly rescue its PPi exchange activity
while tRNA treated with sodium periodate could not
(Figure 3C).
Thus, we conclude that mutation of V85 to a hydro-
philic amino acid such as serine, lysine and glutamate
abolishes the normal ATP-PPi exchange activity of human
TrpRS (Figures 2A and 3A). On the other hand, replacing
V85 with a neutral amino acid such as alanine, or a
hydrophobic amino acid such as leucine, did not produce
the same result (Figures 2A and 3A). Moreover, the more
hydrophobic the side chains at the V85 position, the
higher the enzyme activity.
Interaction between the b1–b2hairpin and tRNA
The V85S single mutation switches human TrpRS
from a tRNA-independent to a tRNA-dependent mode
of tryptophan activation (Figure 2). For the V85S mutant,
the tRNA molecule, not the hydroxyl group at the 30 end,
serves as an activator, which is diﬀerent from ArgRS,
GluRS and GlnRS (Figure 2C). The V85E mutant was
activated to catalyze the ATP-PPi exchange reaction only
in the presence of wild-type bovine tRNA
Trp (Figure 3C).
Figure 2. Enzymatic activities of the V85A, V85S, V90A and V90S
mutants. (A) ATP-PPi exchange activity of the four mutants and wild-
type human TrpRS. To display the whole curve of wt-hTrpRS, we
enlarged the scale of the Y-axis in the boxed inset. (B) Aminoacylation
activity of the four mutants and wild-type human TrpRS. The enzyme
concentrations are 5nM for wild-type human TrpRS (wt-hTrpRS),
20nM for V85A and V90A and 50nM for V85S and V90S.( C) PPi
exchange activity of the V85S mutant in the presence of wild-type
or oxidized bovine tRNA
Trp. The wt-hTrpRS curve is shown in the
boxed inset.
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adenosine of tRNA also can act as an activator, similar to
ArgRS, GluRS and GlnRS. The V85K mutant had barely
detectable enzyme activity.
Based on the recent co-crystal structure of human
TrpRS and bovine tRNA, we concluded that V85 should
be close to a tRNA acceptor stem when tRNA is bound to
human TrpRS (27,35). Thus, the phosphate groups of
tRNAs should be easily aﬀected by the V85 mutation.
To verify our hypothesis, we calculated the Km of tRNA
for the V85S, V85E and V85K mutants. For the V85S
mutant, the Km value was 2.14mM, similar to 1.30mM for
wild-type human TrpRS (Table 1). The Km value was
8.50mM for V85E and 0.294mM for V85K (Table 1).
Therefore, it is reasonable to conclude that the V85S
mutant that leaves the side chain uncharged has little eﬀect
on tRNA binding, so not only wild type but also oxidized
tRNA is able to properly bind to the enzyme to prompt
the ATP-PPi exchange reaction. Because the side chain
of glutamate is negatively charged, the V85E mutation
would push out the negatively charged phosphate groups
of tRNAs, weakening tRNA binding. The V85K mutant,
with a positively charged side chain, can attract the
negatively charged phosphate groups of tRNAs. As a
result, tRNA may be bound to human TrpRS at an
incorrect position when V85 was mutated to a lysine.
Therefore, the fact that the V85K mutant has the lowest
acceptor activity is reasonable.
We next calculated the Km for tRNA and the kcat values
of all the above mutations (Table 1). These varied
dramatically at the b1–b2 hairpin, with Km ranging from




–1. The Km values suggest that V85 and V90 can
interact with tRNA when tRNA binds to human TrpRS.
Thus, it is logical that charge variations of the side
chains at V85 and V90 have the greatest impact on tRNA
acceptor activity.
V85interacts with I311of theAIDQ sequence via by
hydrophobic side chains
Based on the crystal structure of the full-length human
TrpRS (1R6T), we found that V85 is far away from the
substrate-binding pocket (Figure 1A) and therefore could
not directly aﬀect tryptophan activation. However, the
side chain of V85 is only 4.41A ˚ away from the side chain
Table 1. The aminoacylation kinetics constant for wt-hTrpRS, V85A, V85S, V90A, V90S, V85E, V85K, V85L, and V85A/V90A mutants. All Km are
for tRNA







wt-hTrpRS 1.30 0.16 1.37 0.14 1.05 1.00
a
V85A 1.41 0.15 0.476 0.026 0.338 0.322
V85S 2.14 0.54 (2.77 0.77) 10
 2 1.29 10
 2 1.23 10
 2
V90A 18.4 2.2 1.39 0.070 7.55 10
 2 7.19 10
 2
V90S 5.20 0.90 (6.25 0.63) 10
 2 1.20 10
 2 1.14 10
 2
V85E 8.50 1.4 (1.97 0.37) 10
 2 2.32 10
 3 2.21 10
 3
V85K 0.294 0.047 (9.44 2.4) 10
 4 3.21 10
 3 3.06 10
 3
V85L 24.8 5.6 5.11 0.99 0.206 0.196
V85A/V90A 2.23 0.24 (4.71 0.49) 10
 2 2.11 10
 2 2.01 10
 2
aThe activity of wild-type human TrpRS was set to 1.00.
Figure 3. Enzymatic activities of the V85E, V85K and V85L mutants.
(A) ATP-PPi exchange activity of the three mutations and wild-type
human TrpRS. The boxed inset displayed the whole curve of wt-hTrpRS
and the V85L mutant. (B) Aminoacylation activity of the three mutations
and wild-type human TrpRS. The enzyme concentrations are 5nM for
wt-hTrpRS and V85L and 200nM for V85E and V85K. (C) PPi exchange
activity of the V85E and V85K mutants in the presence of wild-type
or oxidized bovine tRNA
Trp. The enlarged scale for wt-hTrpRS and the
85L mutant are shown in the boxed inset.
5938 Nucleic Acids Research, 2007, Vol. 35, No. 17of I311 (Figure 1A). I311 is a residue in the conserved
AIDQ sequence. A310 and D312 interact with the ribose
of ATP through hydrogen bonds to stabilize ATP binding
(35). Combining all ﬁndings, we concluded that V85
may aﬀect I311 through hydrophobic interactions
between their side chains to aﬀect tryptophan activation.
Furthermore, we compared the crystal structure of
unliganded human mini-TrpRS (1ULH), which contains
the b1–b2 hairpin structure at one monomer, with the
unliganded crystal structure of T2-TrpRS (1O5T) in which
the b1–b2 hairpin structure is hydrolyzed. Both the mini-
TrpRS and T2-TrpRS are truncated forms of human
TrpRS at the N-terminus with mini-TrpRS encoding
residues 48–471 and T2-TrpRS encoding residues 94–471.
We found that the AIDQ sequence of mini-TrpRS
assumes a compact form (Figure 4A), while the AIDQ
sequence of T2-TrpRS adopts a loose form (Figure 4A).
When bovine tRNA
Trp binds to T2-TrpRS (2DR2), as
expected, its AIDQ sequence switches to the compact
form (Figure 4B). Therefore, it is reasonable to conclude
that, at least partially, the interaction of V85 with I311 can
induce the AIDQ sequence to an active compact form.
If V85 is mutated to a hydrophilic amino acid that
disrupts the hydrophobic interaction between V85 and
I311 (such as serine, glutamate and lysine), the conforma-
tional change in the AIDQ sequence might not be induced
correctly. Alternatively, because the 30 end of tRNA and
the AIDQ sequence interact (35), tRNA can substitute for
the function of the b1–b2 hairpin.
To conﬁrm our hypothesis, we mutated I311 to valine
and glutamate and determined their enzyme activity.
As we had expected, when the isoleucine was mutated to
acidic glutamate, the normal ATP-PPi exchange activity
of human TrpRS was abolished (Figure 5A), but the
mutant enzyme could still catalyze the tryptophanylation
reaction with decreased eﬃciency (Figure 5B). Wild-type
bovine tRNA
Trp, not the oxidized form, was able to
promote the ATP-PPi exchange reaction (Figure 5C), just
like the V85E mutation. Compared with wild-type human
TrpRS, the I311V mutation had little eﬀect on both the
ATP-PPi exchange reaction and tryptophanylation reac-
tion relative to the large eﬀect of the I311E mutant on
both reactions (Figure 5A and B). Therefore, the above
inference should be true. Relative to the V85E mutant,
the I311E mutant has even lower aminoacylation activity.
The I311E mutant might interfere with the interaction
between the A76 ribose of bovine tRNA
Trp and AIDQ
sequence (35).
The V90mutation enhances the hydrophobic interaction
between V85 andI311
We have found that the V90 mutations had little eﬀect on
the ATP-PPi exchange reaction. Mutants of human
TrpRS at position 90 only showed reduced ATP-PPi
exchange activity. Based on structural analysis of the full-
length human TrpRS (1R6T), we found that the side chain
of V90 is farther away from the side chain of I311 than
that of V85. Thus, V90 should only act as a subsidiary
residue to enhance the hydrophobic interaction between
V85 and I311. Therefore, we constructed a double mutant
of human TrpRS, V85A/V90A. As expected, the behavior
of V85A/V90A was similar to the V85S mutant (Figure 6).
We also calculated the Km and kcat for the V85A/V90A
double mutant, which were 2.23mM and 0.0471S
–1,
respectively (Table 1).
Thereare no Schiff bases formedbetween oxidizedbovine
tRNA
Trp and human TrpRSmutants
Previous studies have shown that tRNA oxidized by
sodium periodate can form Schiﬀ bases with the e-NH2
of lysine residues close to the binding site (33,36),
irreversibly inhibiting enzyme activity. To clarify whether
the oxidized bovine tRNA
Trp can form Schiﬀ bases with
human TrpRS, we pre-incubated the V85E, V85K, V85S,
Figure 4. Structural comparisons of human T2-TrpRS and mini-
TrpRS. (A) Comparison of unliganded T2-TrpRS (1O5T) and mini-
TrpRS (1ULH). (B) Comparison of T2-TrpRS bound to bovine
tRNA
Trp (2DR2) and mini-TrpRS (1ULH). For clarity, the tRNA
molecule of 2DR2 is not displayed, and only part of the N-terminus,
the AIDQ sequence, and the KMSAS loop are colored dark blue
for mini-TrpRS and pink for T2-TrpRS. In both Figure 4A and B, the
b1–b2 hairpin, the AIDQ sequence and the KMSAS loop are indicated
with sky blue dashed ellipses. The conformational change of the AIDQ
sequence is enlarged in the circled ellipse inset.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5939V85A/V90A and I311E mutants with oxidized tRNA for
10min, 20min, 30min and 40min, and then performed the
aminoacylation assay (see Materials and Methods section
for aminoacylation conditions). After 10min, reactions
were stopped and enzyme activity was determined. The
results showed that oxidized tRNA did not inhibit the
activity of the enzymes (Supplementary Figure S1).
Therefore, Schiﬀ bases do not form between oxidized
tRNA and TrpRS.
DISCUSSION
ArgRS, GluRS, GlnRS and Class I LysRS all share the
common feature that is the absolute requirement of tRNA
in the amino acid activation step. For these aaRSs, the
tRNA is postulated to serve as the enzyme activator in
the ﬁrst step and as the substrate in the second step of
aminoacylation. Except for these four enzymes, the other
class I aaRSs do not require the presence of tRNA to
activate amino acid, such as TrpRS. Here, we combined
mutations to illustrate that human TrpRS can be switched
to a tRNA-dependent mode to activate tryptophan by
single or double mutation(s) in the b1–b2 hairpin and
AIDQ sequence. These mutant enzymes were all tested
at a high concentration (>2.5mM) and were unable to
activate tryptophan in the absence of tRNA. This ﬁnding
was unexpected. These mutations abolished the PPi
exchange activity of TrpRS, which can be partially rescued
Figure 6. Enzymatic activities of the V85A/V90A double mutants.
(A) ATP-PPi exchange activity of this mutant and the wild-type human
TrpRS. The enlarged scale is shown in the boxed inset for wt-hTrpRS.
(B) Aminoacylation activity of the V85A/V90A double mutant and
wild-type human TrpRS. The enzyme concentrations are 5nM for wild-
type human TrpRS and 200nM for the V85A/V90A mutant. (C) PPi
exchange activity of the V85A/V90A double mutant in the presence of
wild-type or oxidized bovine tRNA
Trp and wild-type human TrpRS.
The wt-hTrpRS curve is shown in the boxed inset.
Figure 5. Enzymatic activities of the I311E and I311V mutants.
(A) ATP-PPi exchange activity of the two mutants and wild-type human
TrpRS. The boxed inset displayed the whole curve of wt-hTrpRS.
(B) Aminoacylation activity of the two mutants and wild-type human
TrpRS.Theenzymeconcentrationsare5nMforwild-typehumanTrpRS,
50nM for the I311V mutant and 200nM for the I311E mutant. (C) PPi
exchange activity of the I311E mutant in the presence of wild-type
or oxidized bovine tRNA
Trp and wild-type human TrpRS. The enlarged
scale for wt-hTrpRS is shown in the boxed inset.
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comparisons of the tRNA-free and tRNA-bound enzyme
crystals have revealed tRNA-induced enzyme conforma-
tional changes (37–39), which should be responsible for
amino acid activation. The situation for human TrpRS
should be the same and was conﬁrmed by structural
comparison (Figure 4). On the other hand, for wild-type
human TrpRS, V85 should perform the same function, at
least partially, as tRNA in the tryptophan activation
reaction (Figure 4).
Conformational changes in human TrpRS induced by
V85 would presumably require speciﬁc molecular interac-
tions. We have identiﬁed an interface between the
eukaryotic-speciﬁc patch and the catalytic center, which
might be responsible, at least in part, for molecular
interactions that would facilitate tryptophan activation.
This site is deﬁned in human TrpRS by the eukaryotic-
speciﬁc patch that contains V85at the b1–b2 hairpin and
I311at the conserved AIDQ sequence which directly
interacts with ATP, based on the crystal structure of
full-length human TrpRS (40). The side chains of V85 and
I311 are as little as 4.41A ˚ apart. A comparison of the
X-ray crystal structures of T2-TrpRS and mini-TrpRS
(both not bound by substrates) illustrates that the b1–b2
hairpin is responsible for the ‘productive’ form of human
TrpRS (Figure 4). We concluded that, at least partially,
the compact form of the AIDQ sequence of human TrpRS
is ensured by hydrophobic interactions between the side
chains of V85 and I311, because the side chain of V90 is
much farther away from the side chain of I311 than that of
V85. V90 should be a minor residue to interact with I311
by hydrophobic interaction, which was conﬁrmed by the
V85A/V90A double mutant. A310 and D312 are known
to be able to form hydrogen bonds with the ribose of ATP
to stabilize ATP binding. Therefore, if V85 is mutated to
a hydrophilic amino acid, the hydrophobic interaction
between V85 and I311 will be disrupted and the AIDQ
sequence might assume a loose form. As a result, the
hydrogen bond interaction between ATP and the AIDQ
sequence will be disrupted and ATP may not be able
to bind TrpRS stably. Thus, mutated human TrpRS
cannot catalyze tryptophan activation until tRNA is
also bound.
For V85E and I311E, the oxidized tRNA cannot rescue
their PPi exchange activity, but wild-type tRNA still
can (Figures 3C and 5C). After treatment with sodium
periodate, the 20 and 30 hydroxyl groups of tRNA are
oxidized to aldehyde groups. This should not result in any
large changes in the hydrogen bonds between the A76 of
tRNA and residues D312 and Q313 of the AIDQ sequence
(35), otherwise the tRNA oxidized by sodium periodate
would not be able to bind to human TrpRS properly and
rescue the PPi exchange activity of the V85S mutant
and the V85A/V90A double mutants. These results imply
that the 20 or 30 hydroxyl group also can serve as an
activator, just like ArgRS, GluRS and GlnRS. As enzyme
activity proceeds, the 20 or 30 hydroxyl group of A76 will
consequentially interact with the Trp–adenylate inter-
mediate to accept activated tryptophan. The interaction
between tRNA and Trp-adenylate may stabilize ATP
binding allowing the human TrpRS to activate
tryptophan, even though V85 or I311 was mutated to
glutamate. Furthermore, the sequence alignments show
that V85 and V90 are conserved in eukaryotes and
archaebacteria, including the proline and tryptophan in
the b1–b2 hairpin (Figure 1B). Therefore, the b1–b2
hairpin structure of human TrpRS should be conserved in
eukaryotes and archaebacteria and its function should be
the same as that in human TrpRS.
Wild-type human TrpRS or mini-TrpRS does not
require its cognate tRNA to activate tryptophan (41).
However, we can switch its tRNA-independent PPi
exchange activity to a tRNA-dependent mode by
introducing mutations within the eukaryote-speciﬁc
patch (E82–K154), which is not found in prokaryotic
enzymes. It raises the question of whether the tRNA-
independent PPi exchange activity of human TrpRS is an
ancestral feature or has been more recently acquired with
the acquisition of the eukaryote-speciﬁc patch. Our results
cannot give a deﬁnite answer, although it seems that
the partition between tRNA-independent and tRNA-
dependent PPi exchange activity within a single aaRS
can shift dramatically with relative evolutionary ease.
Based on sequence alignment, we recently found a TrpRS
from Pyrococcus horikoshii, a hyper-thermophilic archae-
bacterium. This TrpRS has eukaryotic features, but the
eukaryotic-speciﬁc patch is completely absent in this
enzyme. This archeabacterial TrpRS could provide further
evidence to deﬁne the evolutionary connection between
TrpRS and ArgRS-like aaRSs.
For ArgRS, GluRS, GlnRS and class I LysRS, the
biological signiﬁcance of requiring tRNA as a cofactor to
activate amino acid is unclear. However, a previous study
showed that tRNA binding can help these four class I
aaRSs specially recognize their cognate amino acid. The
co-crystal structure of Thermus thermophilus GluRS and
tRNA
Glu with or without glutamate demonstrated that
the amino acid-binding site of T. thermophilus GluRS is
incomplete and the presence of the cognate tRNA
Glu
facilitates glutamate binding by the enzyme (39). In the
absence of tRNA, T. thermophilus GluRS binds not only
L-glutamate but also noncognate amino acids such as
D-glutamate, L-aspartate and L-glutamine (42). The bind-
ing of the noncognate amino acids is eliminated by
tRNA
Glu binding to the enzyme. Similarly, the co-crystal
structure of E. coli GlnRS indicated that the tRNA itself is
involved in the Gln-AMP-binding site (38). For ArgRS,
the Bacillus stearothermophilus and Neurospora crassa
ArgRSs can bind the cognate arginine only in the presence
of tRNA
Arg (7,10). A similar phenomenon was also
reported for class I LysRS (22). The recently discovered
dual speciﬁcity enzyme, prolyl-tRNA synthetase (ProRS),
can acylate not only proline but also cysteine, although it
can only recognize cysteine in the presence of Trna (43,44).
The existence of aaRSs that can catalyze the synthesis
of more than one aminoacyl-tRNA is assumed to be an
important step in the evolution of these enzymes (45).
tRNA-dependent amino acid recognition may be a relic of
synthetase evolution. However, a recent paper by Carter
et al. (46) showed that the minimal TrpRS catalytic
domain from B. stearothermophilus can still catalyze the
tryptophan activation step without tRNA and also
Nucleic Acids Research, 2007, Vol. 35, No. 17 5941mischarge tRNA. Therefore, the biological signiﬁcance of
tRNA-dependent amino acid recognition remains puz-
zling. Otherwise, is the tRNA-dependent amino acid
recognition inherent to class I aaRSs? Maybe we can get
the answers in the future.
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